G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer

International Journal of Cancer

Volumn 128, Issue 4, 2011, Pages 847-856

  Tang, Yong ^a   Chen, Yakun ^a   Jiang, Hongmei ^a   Robbins, Gregory T ^a   Nie, Daotai ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; colon cancer; GPR43; short chain fatty acids

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BUTYRIC ACID; CASPASE; CYCLIN D3; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; DNA METHYLTRANSFERASE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 43; HISTONE DEACETYLASE; MESSENGER RNA; PROPIONIC ACID; PROTEIN P21; TRICHOSTATIN A; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; COLON; COLON CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG TARGETING; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ACETYLATION; ADENOCARCINOMA; APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELL PROLIFERATION; COLON; COLONIC NEOPLASMS; DNA METHYLATION; FATTY ACIDS, VOLATILE; FLOW CYTOMETRY; HISTONES; HUMANS; IMMUNOENZYME TECHNIQUES; PROMOTER REGIONS, GENETIC; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 78650618692     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25638     Document Type: Article

References (44)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ,. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. Willett WC,. Diet and cancer. Oncologist 2000; 5: 393-404.
3. Fearon ER, Vogelstein B,. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
4. Kinzler KW, Vogelstein B,. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-70.
5. Cook SI, Sellin JH,. Review article: short chain fatty acids in health and disease. Aliment Pharmacol Ther 1998; 12: 499-507.
6. Ruemmele FM, Dionne S, Qureshi I, Sarma DS, Levy E, Seidman EG,. Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). Cell Death Differ 1999; 6: 729-35.
7. Medina V, Edmonds B, Young GP, James R, Appleton S, Zalewski PD,. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res 1997; 57: 3697-707.
8. Kim YS, Tsao D, Siddiqui B, Whitehead JS, Arnstein P, Bennett J, Hicks J,. Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells. Cancer 1980; 45: 1185-92.
9. Heerdt BG, Houston MA, Augenlicht LH,. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res 1994; 54: 3288-93.
10. Young GP, Le Leu RK,. Resistant starch and colorectal neoplasia. J AOAC Int 2004; 87: 775-86.
11. Le Leu RK, Brown IL, Hu Y, Morita T, Esterman A, Young GP,. Effect of dietary resistant starch and protein on colonic fermentation and intestinal tumourigenesis in rats. Carcinogenesis 2007; 28: 240-5.
12. Trock B, Lanza E, Greenwald P,. Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. J Natl Cancer Inst 1990; 82: 650-61.
13. Sellin JH,. SCFAs: the enigma of weak electrolyte transport in the colon. News Physiol Sci 1999; 14: 58-64.
14. Gamet L, Daviaud D, Denis-Pouxviel C, Remesy C, Murat JC,. Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29. Int J Cancer 1992; 52: 286-9.
15. Hague A, Elder DJ, Hicks DJ, Paraskeva C,. Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer 1995; 60: 400-6.
16. Jan G, Belzacq AS, Haouzi D, Rouault A, Metivier D, Kroemer G, Brenner C,. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ 2002; 9: 179-88.
17. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 2003; 278: 11312-9.
18. Nilsson NE, Kotarsky K, Owman C, Olde B,. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun 2003; 303: 1047-52.
19. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart G, van Damme J, Parmentier M, Detheux M,. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 2003; 278: 25481-9.
20. Xiong Y, Miyamoto N, Shibata K, Valasek MA, Motoike T, Kedzierski RM, Yanagisawa M,. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci USA 2004; 101: 1045-50.
21. Senga T, Iwamoto S, Yoshida T, Yokota T, Adachi K, Azuma E, Hamaguchi M, Iwamoto T,. LSSIG is a novel murine leukocyte-specific GPCR that is induced by the activation of STAT3. Blood 2003; 101: 1185-7.
22. Karaki S, Tazoe H, Hayashi H, Kashiwabara H, Tooyama K, Suzuki Y, Kuwahara A,. Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J Mol Histol 2008; 39: 135-42.
23. Karaki S, Mitsui R, Hayashi H, Kato I, Sugiya H, Iwanaga T, Furness JB, Kuwahara A,. Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res 2006; 324: 353-60.
24. Chen Y, Tang Y, Wang MT, Zeng S, Nie D,. Human pregnane X receptor and resistance to chemotherapy in prostate cancer. Cancer Res 2007; 67: 10361-7.
25. Tang S, Bhatia B, Maldonado CJ, Yang P, Newman RA, Liu J, Chandra D, Traag J, Klein RD, Fischer SM, Chopra D, Shen J, et al. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. J Biol Chem 2002; 277: 16189-201.
26. Jenuwein T, Allis CD,. Translating the histone code. Science 2001; 293: 1074-80.
27. Jones PA, Takai D,. The role of DNA methylation in mammalian epigenetics. Science 2001; 293: 1068-70.
28. Yoshida M, Kijima M, Akita M, Beppu T,. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 1990; 265: 17174-9.
29. Fang JY, Lu J, Chen YX, Yang L,. Effects of DNA methylation on expression of tumor suppressor genes and proto-oncogene in human colon cancer cell lines. World J Gastroenterol 2003; 9: 1976-80. (Pubitemid 37168425)
30. Ruas M, Peters G,. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1998; 1378: F115-77.
31. Hengst L, Reed SI,. Inhibitors of the Cip/Kip family. Curr Top Microbiol Immunol 1998; 227: 25-41.
32. Sellin JH, DeSoignie R,. Short-chain fatty acid absorption in rabbit colon in vitro. Gastroenterology 1990; 99: 676-83.
33. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT,. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987; 28: 1221-7.
34. Wolever TM, Josse RG, Leiter LA, Chiasson JL,. Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. Metabolism 1997; 46: 805-11.
35. Matthews GM,. Short-chain fatty acid modulation of apoptosis in gastric and colon cancer cells, Ph.D. thesis, The University of Adelaide, February 2007.
36. Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, Liu XQ, Hauser J, Brattain MG,. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells. Cancer Res 2008; 68: 3152-60.
37. Chen D, Li X, Zhai Z, Shu HB,. A novel zinc finger protein interacts with receptor-interacting protein (RIP) and inhibits tumor necrosis factor (TNF)- and IL1-induced NF-kappa B activation. J Biol Chem 2002; 277: 15985-91.
38. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A,. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 1999; 20: 501-34.
39. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ,. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. Embo J 1999; 18: 1571-83.
40. Flores-Rozas H, Kelman Z, Dean FB, Pan ZQ, Harper JW, Elledge SJ, O'Donnell M, Hurwitz J,. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc Natl Acad Sci USA 1994; 91: 8655-9.
41. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B,. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-25.
42. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T,. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995; 9: 935-44.
43. Serrano M, Hannon GJ, Beach D,. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704-7.
44. Hannon GJ, Beach D,. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994; 371: 257-61.